What you can expect when taking part in a clinical trial
It’s important that our volunteers have a great experience with us from start to finish. Here we outline what you can expect from your initial point of contact to the end of your participation and beyond.
Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
A first of a kind trial in the fight against malaria
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Patient with rare bleeding disorder becomes first to test new treatment
The thousands of patients who participate in Richmond’s trials are helping to advance medical science and save lives and, in the process, some make history. In a film released today, one trial participant tells her story.
Recruiting breastfeeding mothers into clinical trials through transparent and sensitive conversations
Richmond Pharmacology's study on merotocin showed low transfer to breast milk, overcoming recruitment challenges through proximity to a maternity ward.
Announcement of Jorg Becoming President Elect
Richmond Pharmacology announces CEO Dr. Jorg Taubel's appointment as President Elect of Germany's AGAH, where he will enhance early-phase clinical research over a six-year term.